← All trials
NCT01408836
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 1995
- Primary completion
- Jun 1, 2003
- Completion date
- Dec 1, 2003
- First posted
- —
- Last posted
- —
- Enrollment
- 150
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of CambridgeLead sponsor
- University of CopenhagenStudy director
- University of GroningenCollaborator
- University of LondonCollaborator
- University of HelsinkiCollaborator
- Lund UniversityCollaborator
- University of BirminghamCollaborator
- Fundació ACECollaborator
- University of LeicesterCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.